Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Aardvark Therapeutics, Inc. Common Stock (AARD)

Compare
17.24
+2.34
+(15.70%)
As of 3:34:12 PM EST. Market Open.
All numbers in thousands
Download
Breakdown
12/31/2023
12/31/2022
Total Assets
10,536
16,757
Total Liabilities Net Minority Interest
45,338
44,680
Total Equity Gross Minority Interest
-34,802
-27,923
Total Capitalization
-34,802
-27,923
Common Stock Equity
-34,802
-27,923
Capital Lease Obligations
162
262
Net Tangible Assets
-34,802
-27,923
Working Capital
8,986
15,896
Invested Capital
-34,802
-27,923
Tangible Book Value
-34,802
-27,923
Total Debt
162
262
12/31/2022 - 2/13/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MAZE Maze Therapeutics, Inc.
12.29
-2.15%
 
MTSR Metsera, Inc.
31.50
-1.29%
 
SION Sionna Therapeutics, Inc.
20.28
+1.47%
 
SEPN Septerna, Inc.
5.97
+7.57%
 
SRNE Sorrento Therapeutics, Inc.
0.0005
0.00%
 
CELU Celularity Inc.
1.8000
-4.27%
 
ANAB AnaptysBio, Inc.
19.02
-3.03%
 
STOK Stoke Therapeutics, Inc.
8.55
-8.07%
 
VERA Vera Therapeutics, Inc.
29.57
+0.17%
 
CRBP Corbus Pharmaceuticals Holdings, Inc.
8.15
+4.49%